AI Engines For more Details: Perplexity Kagi Labs You
Dental Health: Maltitol is non-cariogenic, meaning it does not promote tooth decay. Unlike regular sugar, maltitol does not ferment in the mouth and produce acids that can erode tooth enamel. Therefore, it is often used in sugar-free candies and chewing gums as a sweetener that is less damaging to dental health.
Blood Sugar Control: Maltitol has a lower glycemic index compared to sucrose (table sugar), meaning it causes a smaller and slower increase in blood sugar levels after consumption. This makes maltitol a suitable sugar substitute for people with diabetes or those who need to control their blood sugar levels. However, it's important to note that maltitol still has a caloric value and can affect blood sugar levels, albeit to a lesser extent than sucrose.
Gastrointestinal Effects: Maltitol belongs to a class of compounds known as sugar alcohols or polyols. When consumed in large amounts, sugar alcohols like maltitol can have a laxative effect and cause gastrointestinal discomfort, including bloating, gas, and diarrhea. This is because sugar alcohols are partially absorbed in the small intestine and can ferment in the large intestine, leading to osmotic effects and changes in bowel habits.
Weight Management: Maltitol is often used as a sugar substitute in "diet" or low-calorie foods because it provides fewer calories than sucrose. However, it's important to note that maltitol still contributes calories and may not necessarily aid in weight loss if consumed in excess. Some individuals may also experience increased cravings for sweet foods when consuming products containing maltitol, which could potentially counteract weight management efforts.
Blood Lipid Levels: Limited research suggests that maltitol may have neutral or slightly beneficial effects on blood lipid levels, including total cholesterol and triglycerides. However, more studies are needed to fully understand the impact of maltitol consumption on lipid metabolism and cardiovascular health.
Glycemic Response: While maltitol has a lower glycemic index than sucrose, its consumption can still lead to increases in blood sugar levels, particularly in sensitive individuals or when consumed in large amounts. People with diabetes or insulin resistance should monitor their blood sugar levels carefully when consuming products containing maltitol.
| Rank | Probiotic | Impact |
|---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Ankylosing spondylitis | 0.6 | -0.6 | |
| Anorexia Nervosa | 0.6 | -0.6 | |
| Antiphospholipid syndrome (APS) | 0.2 | -0.2 | |
| Autism | 0.6 | -0.6 | |
| Barrett esophagus cancer | 1.2 | 1.2 | |
| Celiac Disease | 0.6 | 0.3 | 1 |
| Chronic Fatigue Syndrome | 0.6 | -0.6 | |
| COVID-19 | 0.8 | -0.8 | |
| Crohn's Disease | 0.6 | -0.6 | |
| Depression | 0.6 | -0.6 | |
| Eosinophilic Esophagitis | 0.6 | 0.6 | |
| Epilepsy | 0.6 | -0.6 | |
| Graves' disease | 0.9 | 0.9 | |
| Halitosis | 0.6 | -0.6 | |
| Inflammatory Bowel Disease | 0.8 | -0.8 | |
| Liver Cirrhosis | 0.6 | 0.6 | 0 |
| Long COVID | 1.4 | -1.4 | |
| Mood Disorders | 0.9 | -0.9 | |
| multiple chemical sensitivity [MCS] | 0.6 | -0.6 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.3 | 0.3 | |
| Obesity | 0.2 | 0.2 | |
| obsessive-compulsive disorder | 0.6 | 0.6 | |
| Osteoporosis | 0.6 | -0.6 | |
| Parkinson's Disease | 0.2 | -0.2 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.8 | -0.8 | |
| Schizophrenia | 0.9 | -0.9 | |
| Systemic Lupus Erythematosus | 0.2 | -0.2 | |
| Ulcerative colitis | 0.6 | -0.6 | |
| Unhealthy Ageing | 0.6 | -0.6 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.